Clipping of news on Brazilian Culture, Law and Citizenship
01.27.2016
This article was translated by an automatic translation system, and was therefore not reviewed by people.
transparent image
The National Health Surveillance Agency (Anvisa) suspended the marketing and use of several batches of the drug Natrilix 1.5 mg SR (indapamide), medicine used to treat high blood pressure. The measure was taken because of a change in the formula that was done without prior knowledge of the regulatory agency.
Natrilix had lots suspended by ANVISA
According to Anvisa, the Servier Laboratories of Brazil Ltda, its maker, changed the tablet composition failing to use pharmaceutical ingredient HPMC 15000 MPAS, compensating with additional amount of pharmaceutical ingredient HPMC 4000 MPAS.
According to the regulator, this may have affected the efficiency of the drug.
Check out lots suspended:
3003185, 3003432, 3003441, 3003442, 3003717, 3003573, 3003574, 3003575, 3003718, 3003719, 3003720, 3003721, 3003874, 3003875, 3003876, 3003877, 3004019, 3004021, 3004022, 3004023, 3004024, 3004213, 3004214, 3004215, 3004216, 3004415, 3004416, 3004417, 3004418, 3004419, 3004612, 3004613, 3004614, 3004615, 3004697, 3004698, 3004699, 3004700, 3004909, 3004910, 3004911, 3004912, 3004913, 3005016, 3005017, 3005018, 3005019, 3005222, 3005223, 3005224, 3005225, 3005498, 3005499, 3005500, 3005501, 3005502, 3005687, 3005688 and 3005689
Read more: http://extra.globo.com/noticias/economia/anvisa-proibe-venda-uso-de-lotes-do-remedio-natrilix-18550515.html#ixzz3yRkPetY5
Source: Extra
Our news are taken in full of our partner sites. For this reason, we can not change their content even in cases of typographical errors.
transparent image
This article was translated by an automatic translation system, and was therefore not reviewed by people.